PATENT CLAIM ANALYSIS

Application Number: 15866303
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 28):
A method for preparing a co-crystal of  claim 1 , the method comprising:\n (i) mixing the substituted glycine compound and the co-former in a solvent at a temperature of about 40-110\u00b0 C. to form a saturated solution, wherein the substituted glycine compound and the co-former are at a molar ratio of 10:1 to 1:10; (ii) further heating the solution at a temperature of about 40-110\u00b0 C. for 1-10 hours; (iii) cooling the solution at a temperature of about 4-30\u00b0 C. for 10-36 hours to allow the formation of the co-crystal; and (iv) collecting the co-crystal formed in (iii).

Metadata:
- Claim Count in Document: 37.0
- Percentile: 86.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15430750', '15188545', '14358606', '14799281', '14777018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7532133677108075
- 35 USC 102 Novelty (BERT): 0.5822763197086883
- Combined Prediction Score: 0.7361196629105955
- Mean Citation Score: 320.9926200000001
- Max Citation Score: 471.8377
- Similarity Product: 461.65995126454834

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test